Medtronic launches spinal tech; Shutdown halts NIH trial enrollment;

@FierceMedDev: Lensar hauls in $87M for laser eye surgery tech. News | Follow @FierceMedDev

@MarkHFierce: FierceDiagnostics has another great crop of stories for you. Check it out | Follow @MarkHFierce

@MichaelGFierce: ICYMI: Oral peptide delivery biz Enteris lands Nordic partnership. More from FierceDrugDelivery | Follow @MichaelGFierce

> Medtronic ($MDT) has launched its Cornerstone-SR Alliance spinal cage in Europe, marketing the device as a step forward in the treatment of disc disease. Release

> Shares of AngioDynamics ($ANGO) have jumped more than 20% since September, Forbes notes, and the New York devicemaker is primed for more success. Article

> Lombard Medical is expanding its U.K. manufacturing presence to meet increased demand for its FDA-approved Aorfix device. More

> The Washington Post's editorial board has come out against a repeal of the medical device tax, arguing that caving to the industry would only encourage other interest groups to pursue the same strategy. Column

> The ongoing government shutdown has halted clinical trial enrollment at the National Institutes of Health. Article

Biotech News

@FierceBiotech: ICYMI: Top 15 highest paid biopharma R&D chiefs. Special report | Follow @FierceBiotech

@JohnCFierce: The turnaround plan: stay put, target drugs, more deals--John Reed sets out on a long-distance run at Roche's pRED. Feature | Follow @JohnCFierce

@DamianFierce: Updated story on Frazier's $377M new fund with comments from General Partner Jamie Topper. ICYMI yesterday | Follow @DamianFierce

@EmilyMFierce: NIH Feels Multiplying Effects of Government Shutdown. Article from Scientific American | Follow @EmilyMFierce

> Analyst: More Lilly R&D failures likely to trigger 'savage cost cuts.' More

> Cancer biotech upstart nabs $33M A round for R&D work, Array collaboration. Story

> J&J makes an R&D splash with $42M venture play, biotech collaborations. Report

> Shutdown halts NIH drug trials as researchers hit brakes on preclinical research. Article

Pharma News

@FiercePharma: Funnily enough, we publish Top 15 Drug Launch Superstars, and 1000s click thru to last year's Top 10 Launch Disasters. | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: Acino agrees to $439M takeover offer from private equity firms. More | Follow @CarlyHFierce

> Lilly warns of 'challenging' bid for 2014 sales goal, thanks to yen, emerging markets. News

> Novartis, Sanofi, Biogen tout new MS drug research. Story

Vaccines News

> NIH expands vaccine clinical trial network. Item

> CDC reports across-the-board rises in flu vaccine uptake. Report

> Researchers highlight knowledge gaps hindering cancer vaccines. Story

> Vaccines spared as Merck takes ax to R&D. More

> Government shutdown forces CDC to halt seasonal flu program. Article

Pharma Manufacturing News

@EricPFierce: Hospira faces more vial problems. FDA and co. say glass strands pose potential health threat. More | Follow @EricPFierce

> Ranbaxy denies FDA issues will lead to layoffs. Item

> SCM offers 'blank canvas' to sterile injectable clients. Story

> FDA threatens drugmaker with ban for not paying user fee. Article

> CML, AAIPharma join forces to create CMC specialist. More

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.